Here's a re-cap of last week's action on Wall Street, with a look at the week ahead. Equities slumped last week, but bullish factors prevail. Read More

Here are the pros and cons of a second paycheck for a family with kids. The calculations might surprise you. Read More

This video looks at the ABBV trade, which is expiring January 5. We're making a 33% gain on this trade, over a period of 3 ½ months. Read More

Just when you thought the pandemic was behind us, respiratory illnesses such as the coronavirus and influenza are on the rise. Read More

Electronic health records are emerging as among the most prevalent targets for fraud and cyber theft. Take these protective measures now. Read More

From the state grassroots to Congress, here’s a review of key pending legislative developments in marijuana (and psychedelics) for 2024. Read More

The stock market’s upward trajectory of 2023 is likely to continue in 2024, but yesterday's home runs don't win today's games. Read More

This innovative method of growing crops can help the world break through the limitation of land availability. Read More

Here’s a review of the best and worst performing stocks last year. As the new year gets underway, the laggards are poised to shine. Read More

2023 was a rebound year for the market. However, the rally was largely driven by a handful of mega-cap tech stocks rather than a broad-based rally suggesting a robust underlying economy. Read More